Evidence map›Paper›PMID 41607649›Full record

ReviewMolecular syndromology2025

A Case of

Ayşe Burcu Doğan Arı, Ayberk Türkyılmaz, Avni Merter Keçeli, Mehmet Önen, Esra Kılıç

Abstract readReview
In one paragraph

Review in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ayşe Burcu Doğan ArıDepartment of Pediatric Genetics, Ankara Bilkent City Children's Hospital, University of Health Sciences, Ankara, Türkiye.
Ayberk TürkyılmazDepartment of Medical Genetics, Karadeniz Technical University Faculty of Medicine, Trabzon, Türkiye.
Avni Merter KeçeliDepartment of Pediatric Radiology, Ankara Bilkent City Children's Hospital, University of Health Sciences, Ankara, Türkiye.
Mehmet ÖnenDepartment of Ophthalmology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Türkiye.
Esra KılıçDepartment of Pediatric Genetics, Ankara Bilkent City Children's Hospital, University of Health Sciences, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Kenny-Caffey syndrome type 2 (KCS2, #OMIM127000) is an extremely rare skeletal dysplasia characterized by characteristic facial features, relative macrocephaly, short stature, hypoparathyroidism, hypocalcemia, cortical thickening of tubular bones, and medullary stenosis. It is caused by the Family with Sequence Similarity 111 Member A ( Case Presentation: Herein, we report a 7-year-old boy with microphthalmia, delayed anterior fontanelle closure, short stature, hypoparathyroidism, hypocalcemia, cortical thickening of tubular bones, and medullary stenosis. The presented patient had microcephaly, maculopathy, and craniosynostosis as rare distinct features. Microtia, lacunar skull appearance, and Arnold-Chiari malformation were present only in the reported patient. A diagnosis of KCS2 was considered with the clinical and radiological findings. Whole-exome sequencing identified a heterozygous pathogenic hotspot variant, c.1706G>A p.Arg569His (NM_001312909.2), in the Conclusion: Accurate diagnosis plays a critical role in enhancing clinical awareness, improving patient management, and offering appropriate genetic counseling for affected families.

Indexed as

CraniosynostosisFAM111AHypoparathyroidismMaculopathyMicrocephalyMicrophthalmiaShort stature

Identifiers

PMID41607649
PMCPMC12846312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.